Inmune Bio INMB Balance Sheet (2017-2026)

NASDAQ INMB
$1.10 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Inmune Bio Quarterly Balance Sheet

Periods 36 quarters
Latest Sep 2026

Inmune Bio reported total assets of $0.02B and total liabilities of $0.00B for the quarter ended Sep 2026, down 35.5% year over year. This balance sheet covers 36 quarters of results from Dec 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
74.81M66.73M61.21M57.41M52.15M51.00M47.83M41.81M35.85M26.00M31.07M33.55M20.92M19.34M33.37M27.73M24.75M21.36M18.41M16.33M
Cash & Current Investments
74.81M66.73M61.21M57.41M52.15M51.00M47.83M41.81M35.85M26.00M31.07M33.55M20.92M19.34M33.37M27.73M24.75M21.36M18.41M16.33M
Receivables - NetNet Receivables
4.91M5.15M4.93M4.42M8.10M1.81M1.93M2.09M1.91M2.13M3.14M1.11M1.18M1.28M1.61M1.70M4.28M0.48M4.41M1.21M
Receivables - OtherOther Receivables
0.30M0.20M0.20M0.10M0.36M0.54M0.56M0.59M0.55M0.23M0.13M0.55M0.76M0.26M0.29M0.35M0.52M
Receivables
5.21M5.35M5.13M4.52M8.46M1.81M1.93M2.09M2.44M2.69M3.73M1.65M1.41M1.42M2.16M2.46M4.54M0.77M4.77M1.73M
Current Deferred Tax AssetsCurrent Deferred Tax
0.00M1.05M
Prepaid Assets
2.28M4.67M4.22M4.60M4.03M3.63M2.71M1.54M1.51M1.11M1.01M0.86M0.33M0.21M0.51M0.47M0.60M0.69M0.62M0.65M
Current Assets
82.61M77.06M70.55M66.66M64.68M56.88M52.61M45.61M39.94M29.82M35.50M35.85M22.66M20.96M36.03M30.67M29.89M22.82M23.80M18.71M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.71M0.88M0.96M0.90M1.26M1.19M
Intangibles
16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M0.30M4.11M
Goodwill & Intangibles
16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M16.51M0.30M4.11M
Long-Term Deferred Tax
25.69M34.71M
Other Non-Current Assets
0.10M0.10M0.10M0.10M0.10M0.10M0.13M0.13M0.13M0.11M0.08M0.08M0.08M0.05M0.57M0.75M0.60M0.68M0.54M0.53M
Non-Current Assets
17.34M17.29M17.26M17.14M17.12M17.10M17.11M17.09M17.06M17.01M16.96M16.93M16.90M16.84M1.65M2.69M2.46M3.00M3.05M2.80M
Assets
99.95M94.35M87.81M83.80M81.80M73.98M69.72M62.70M57.00M46.83M52.45M52.78M39.56M37.80M37.68M33.36M32.35M25.82M26.85M21.51M
Liabilities
Current Liabilities
Accounts Payables
3.73M2.55M1.69M3.47M5.21M2.08M2.39M3.68M7.90M9.29M9.28M10.59M6.54M7.20M7.67M6.88M7.77M4.66M5.05M2.20M
Notes Payables
0.09M0.12M0.13M0.13M0.14M0.14M0.15M0.62M
Payables
3.73M2.55M1.69M3.47M5.29M2.08M2.39M3.68M8.02M9.42M9.41M10.73M6.68M7.34M7.67M6.88M8.39M4.66M5.05M2.20M
Accumulated Expenses
0.08M0.01M0.01M0.01M0.01M0.01M0.01M0.08M0.04M0.06M0.14M0.06M0.03M0.10M0.18M0.03M0.03M0.03M0.03M
Other Accumulated Expenses
0.47M0.58M0.48M0.78M0.62M0.59M0.56M0.50M0.49M0.52M0.52M0.55M0.52M0.48M0.51M0.03M0.03M
Short term Debt
2.50M5.00M7.50M10.00M10.00M9.92M7.46M4.98M2.49M
Current Leases
-0.14M-0.12M-0.14M
Total Current Liabilities
4.36M3.23M2.29M6.90M10.92M10.28M13.06M14.36M18.47M17.45M15.05M13.82M7.22M7.93M8.59M7.36M8.42M5.39M5.89M2.92M
Non-Current Liabilities
Capital Leases
0.42M0.52M0.49M0.42M0.38M0.35M
Non-Current Debt
14.46M14.51M14.57M12.13M9.70M7.26M4.82M2.38M7.50M5.00M2.50M
Non-Current Deferred Revenue
Preferred Stock Liabilities
0.80M0.80M0.80M0.80M0.80M
Minority Interest
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases
0.28M0.68M0.65M0.61M0.53M0.50M0.46M0.43M0.40M0.36M0.32M0.28M0.24M0.20M0.23M0.62M0.41M0.81M0.59M0.52M
Other Non-Current Liabilities
0.38M0.46M0.55M0.64M0.73M0.80M-0.55M10.47M2.14M3.10M
Total Non-Current Liabilities
19.72M18.71M17.50M19.63M21.14M18.05M18.34M17.96M20.21M5.70M5.32M5.73M
Total Liabilities
19.72M18.71M17.88M20.09M21.69M18.68M19.07M18.77M19.66M18.61M16.17M14.11M7.47M8.13M8.82M7.98M8.83M6.19M6.48M3.44M
Shareholder's Equity
Total Debt
14.46M14.51M14.57M14.63M14.78M14.76M14.82M12.38M10.04M15.08M10.11M5.13M15.14M0.15M0.62M
Common Equity
80.23M75.64M69.93M63.71M60.10M55.30M50.65M43.93M37.34M28.22M36.28M38.68M32.10M29.67M28.87M25.38M23.52M19.62M20.36M18.07M
Liabilities and Shareholders Equity
99.95M94.35M87.81M83.80M81.80M73.98M69.72M62.70M57.00M46.83M52.45M52.78M39.56M37.80M37.68M33.36M32.35M25.82M26.85M21.51M
Treasury Stock
0.80M
Retained Earnings
-63.72M70.62M77.46M-85.18M-91.01M-97.55M-104.05M-112.61M-121.02M-132.05M-141.79M-153.89M-163.10M-172.84M-197.30M-203.77M-209.04M-214.44M-215.72M-220.44M
Preferred Shares
0.000.000.000.00

Inmune Bio Balance Sheet API

Pull Inmune Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INMB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY